(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Earnings Snapshot: A Preview of CyberArk, Exelixis, and Gevo

  • May 10th, 2025
  • 91 views

Several companies are preparing to report their quarterly earnings on Tuesday, May 13, including:

CyberArk Software Ltd. (Nasdaq: CYBR), a cybersecurity firm specializing in identity security and privileged access management, will release its first-quarter 2025 financial results before the U.S. markets open. Analysts expect earnings per share (EPS) of $0.79 on revenue of $305.58 million. $CYBR closed Friday’s session at $359.51, down 1.36% (-$4.95).

Exelixis, Inc. (Nasdaq: EXEL), a biotechnology company focused on cancer therapeutics, is scheduled to report its first-quarter 2025 earnings after the close of trading. The consensus forecast calls for EPS of $0.44 on revenue of $500.96 million. $EXEL fell 0.90% (-$0.33) on Friday, ending the session at $36.17.

Gevo, Inc. (Nasdaq: GEVO), a renewable chemicals and advanced biofuels company, will announce its first-quarter 2025 financial results after the market closes. Wall Street expects a loss of $0.10 per share on revenue of $26.35 million. $GEVO gained 1.75% (+$0.02) on Friday to close at $1.16.

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13